The volcano plot highlights CD72, a BCR co-receptor downregulating BCR signaling, to be increased in expression in low CAD severity patients, and ITGAX or CD11c, a B-cell activation marker, to be increased in high CAD severity patients (Figure 6D). Here, ITGAX is linked to coronary artery disorder.